- 1Department of Integrated Traditional and Western Medicine, West China Hospital, Sichuan University, Chengdu, China
- 2Sichuan Second Chinese Medicine Hospital, Chengdu, China
- 3Chengdu First People's Hospital, Chengdu, China
- 4Chongqing Emergency Medical Center, Chongqing, China
- 5Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Chengdu, China
The aim of this study was to observe the clinical effects and brain electrical potential changes following acupuncture in the treatment of insomnia patients with mood disorders. Ninety patients with insomnia who met the inclusion criteria were randomly divided into the active acupuncture group (AA group, n = 44) and sham acupuncture group (SA group, n = 46) at a ratio of 1:1. The primary outcome was the total score of the Pittsburgh Sleep Quality Index (PSQI), and the secondary outcomes were the total effective rate, Self-Rating Anxiety Scale (SAS), Self-Rating Depression Scale (SDS) scores, and values of steady-state visual evoked potentials (SSVEP). The two groups received acupuncture or sham acupuncture 10 times (2 weeks). Finally, the total PSQI scores of the AA group and SA group were significantly different (p < 0.05) at 2 weeks (6.11 ± 2.33 vs. 10.37 ± 4.73), 6 weeks (6.27 ± 1.39 vs. 11.93 ± 3.07), 18 weeks (6.32 ± 2.84 vs. 11.78 ± 2.95) and 42 weeks (8.05 ± 3.14 vs. 12.54 ± 2.81). Further analysis found that AA group patients received acupuncture treatment at any age after the same effect (p > 0.05). The SAS and SDS scores of the AA group were also significantly different from those of the SA group at each assessment time point (p < 0.05). The total effective rate of the AA group was 81.82%, while that of the SA group was 30.43% (p < 0.05). There was no significant difference between the AA group and SA group only in the brain potential of the parietal lobe (F4), left temporal lobe (C3) and right temporal lobe (T8) (P > 0.05), but there was a significant difference between other brain regions (P < 0.05). In addition, correlation analysis showed that there was a certain positive correlation between the total PSQI score, SAS score, efficacy level, and SSVEP value in the AA group as follows: C4 and the total PSQI score (r = 0.595, P = 0.041), F3 and SAS score (r = 0.604, P = 0.037), FPz and efficiency level of the frontal lobe (r = 0.581, P = 0.048), and O2 and efficiency level of the occipital lobe (r = 0.704, P = 0.011). Therefore, acupuncture have a good clinical effect on patients with insomnia and emotional disorders and have a significant regulatory effect on abnormally excited brain potentials.
1. Introduction
Insomnia is a painful and disabling condition that affects a large proportion of the general population. It is a risk factor for impaired functioning and other medical and mental disorders (1). Approximately 10–20% of the world's population suffers from insomnia, and there has been an increased incidence of insomnia worldwide (2). The prevalence of insomnia among Chinese adults reaches up to 19.6% (2). Moreover, insomnia is 1.5 times more common in women than in men (3). Long-term chronic insomnia can cause major health problems and other chronic diseases, such as diabetes (4), obesity (5), and mood disorders (6). Insomnia may be a symptom of other diseases (e.g., stroke) and often coexists with mental and physical health conditions (7).
Insomnia is a cross-diagnostic symptom associated with the development of mental disorders and is most closely related to depression (8). While developing sleep disorders, depression also has a positive influence on mood adjustment (9). The economic and treatment costs for insomnia are also high, totaling more than 100 billion US dollars each year. The indirect costs of productivity losses caused by insomnia include lower work performance, increased healthcare utilization, and increased accident risks (10). Psychological treatment methods such as cognitive behavioral therapy for insomnia (CBT-I) are internationally recommended treatment options for insomnia.
Further evidence from meta-analysis results has shown that compared with fake acupuncture/placebo acupuncture or the effects of waiting for treatment, acupuncture can increase total sleep time, improve sleep efficiency, reduce wakefulness after falling asleep, and reduce the number of awakenings. (11). In addition, the results from our previous research have also confirmed that acupuncture can significantly improve the sleep quality of patients with insomnia affected by mood disorders and that the posttreatment effect can last for more than 6 weeks (12).
However, these issues remain unexplored in the literature. Previous studies have shown that the efficacy evaluation of acupuncture for insomnia is still mainly based on the scale, but there have been few studies using steady-state visual evoked potential (SSVEP) as an objective indicator to evaluate the improvement of sleep quality. Brain computer interface (BCI) technology provides a new cognitive channel for human beings by encoding and decoding brain activity. SSVEP-based BCI stands out from other BCI paradigms because of its advantages of being noninvasive, requiring little user training, and yielding a high information transfer rate (13). SSVEP are widely used in electroencephalogram (EEG) responses elicited by periodic visual stimuli. It has also been widely used to record mood changes (14) as a research tool in social and emotional neuroscience (15).
Much remains to be known about the key mechanisms regulating the cerebral cortex. Therefore, to determine whether acupuncture is an effective treatment option for patients with insomnia, a technique is needed to track the transient electrophysiological effects of acupuncture and to record the cortex's response to electrophysiological changes. Based on the above discussion, we observed the clinical efficacy and brain electrical potential changes of patients with insomnia and emotional disorders treated with acupuncture for the first time, taking the brain potential based on the SSVEP as an indicator and combining it with the clinical scale.
2. Research methods
2.1. Ethics and design
The design and reporting of our controlled trials conformed to the following principles: The Uniform Standards for Reporting Trials (CONSORT) and the Standards for Reporting Interventions in Acupuncture Clinical Trials (STRICTA) Guidelines (16, 17). After obtaining ethical approval from the Sichuan Traditional Chinese Medicine (TCM) Regional Ethical Review Committee (No. 2013KL-016), we started to recruit patients for the study. Due to the maintenance of the Chinese clinical trial registration website, this study was reregistered on October 18, 2018 (ChiCTR1800018958). All patients or authorized guardians signed written informed consent forms.
2.2. Participants
The insomnia patients in this study were recruited through outpatient advertisements and recommendations. All patients received free treatment in the Acupuncture Department of Sichuan Provincial Hospital of Traditional Chinese Medicine in China between May of 2014 and August of 2016. The diagnostic criteria for patients with insomnia are based on the “Diagnostic and Statistical Manual 5 criteria” (18).
Inclusion criteria were as follows: patients who met the diagnostic criteria for insomnia (male or female 18–65 years old); patients in whom insomnia symptoms occurred at least 3 times a week and lasted for more than 1 month; and patients with insomnia who had not taken any anti-insomnia drugs before. There were notable symptoms of anxiety and depression or withdrawal anxiety in patients for more than 7 days (PSQI score >7, SAS score ≥50, SDS score ≥50). Informed consent was obtained from the patients.
Exclusion criteria were as follows: patients who had systemic diseases such as psychosomatic disorder, fever, cough or serious diseases involving vital organs and the haematopoietic system; patients who were alcohol- and drug-dependent or were pregnant or lactating; and patients who participated in other studies.
2.3. Sample size calculation
Previous studies (19) have found a difference of at least 2.7 points in PSQI scores between active acupuncture treatment and sham acupuncture treatment. We expected a 3.2 point difference in active vs. sham acupuncture treatment in this study. Therefore, at the significance level of 0.05, the difference in detection ability between the two groups was 95%, and the sample size was 40 in each group. Considering a drop-out rate of 10%, the total sample size required was 44 for each group in this study.
2.4. Randomization and blinding
The random number table was generated using SPSS 22.0® software. The random Arabic numeral 0 represents the active acupuncture (AA) group, and 1 represents the sham acupuncture (SA) group. The random distribution cards containing random numbers, serial numbers, and groups and were put in opaque, serial-numbered, leather envelopes. Insomnia patients then unsealed the envelopes after meeting the inclusion criteria according to the order of visit. The included patients were randomly divided into the AA and SA groups at a ratio of 1:1. This random assignment is single-blind, and the patients do not know which group they are in. Due to the particularity of the acupuncture therapy, acupuncture treatment allocation was concealed from everyone (e.g., evaluators and data processing statisticians) except the acupuncturist.
2.5. Intervention protocols
The acupuncture treatments in this study were all completed by the same acupuncturist, who had a master's degree and at least 5 years of clinical experience. The acupuncturist chose the same acupuncture points in the patients from both the AA group and the SA group (Table 1, Figure 1). These acupuncture points included bilateral Anmian (EX-HN22), Neiguan (PC6), Shenmen (HT7), Hegu (LI4), Zusanli (ST36), Zhaohai (KI6), Shenmai (BL62) and Taichong (LR3). The acupuncturist used the Park Sham Acupuncture Device (the PSD) to match real needles and blunt needles in both groups (the PSD approval number: 9018390000, DONGBANG Acupuncture Inc.) (Figure 2). The 8 acupoints we selected were artificially stimulated every 15 min, and the duration of each acupoint was 5 s. Patients are treated once a day for 30 min. The treatment was continued for five consecutive days, followed by 2 days of rest. Both the AA group and the SA group received 10 acupuncture (2 weeks) treatments. The follow-up period was half a year, with assessments completed at 6, 18, and 42 weeks.
Patients were not allowed to take any sleep medications during the entire study period. However, patients who could not tolerate sleep disorders in special circumstances were allowed to take estazolam tablets as a rescue medication (0.5–2 mg, approval number: H37023047, Shandong Xinyi Pharmaceutical Co., Ltd.) before going to bed. After their condition was relieved, the patients were asked to stop taking the medication immediately. Their medications were recorded in a notebook. The trial flow diagram is shown in Figure 3.
Figure 3. Trial flow diagram (The Screening, Enrolment, Randomization, Interventions, Follow-up, and Analysis). ITT indicates intention to treat.
2.5.1. Active acupuncture group
We allowed patients to lie quietly in bed during acupuncture treatment. After the acupuncturist disinfected their hands and the patients' acupoint skin with 75% alcohol, the Xin Xinglin disposable needle (0.30 × 25 mm/0.30 × 40 mm) was used, together with the PSD (12). The acupuncturist exposed the needle tip and used a suitable insertion method to penetrate the needle through the skin at acupuncture points while sticking the PSD to the skin at the same time. The angle and depth of needle insertion into each acupoint are shown in Table 1. During the entire 30 min needle retention period, the acupuncturist rotated or lifted the needle every 10 min to achieve the “deqi” sensation (pain, heaviness, numbness, swelling or radiation).
2.5.2. Sham acupuncture group
The acupuncturist used the PSD combined with a blunt needle (0.30 × 25 mm/0.30 × 40 mm) in treating the patients in the SA group. Blunt needle is composed of a hollow needle shaft that can be stretched and a blunt needle head (20). The acupuncturist completed the same disinfection process as used in the AA group and then tapped the blunt needle of the PSD gently against the surface of the skin at the acupuncture points. The blunt needle was not manipulated to minimize any physiological effects. In the SA group, unless the patients did not experience “deqi”, the operations were the same as those conducted in the AA group, including acupoint selection, needle placement times, and needle withdrawal methods (21).
2.6. Primary outcomes
We completed PSQI assessments at baseline, after treatment (week 2), and during follow-up (weeks 6, 18, and 42). Each observation index is scored from 0 to 3 points, and the total score ranges from 0 to 21 points. The higher the score, the worse the sleep quality (22).
2.7. Secondary outcomes
According to the “Guiding Principles of Clinical Research on the Treatment of Insomnia with New Traditional Chinese Medicines”, the criteria for measuring the treatment efficacy in insomnia are established as follows: (1) Clinically cured: Sleep returns to normal, or normal night sleep lasts more than 6 h. There is an increase in deep sleep. Patients are full of energy after wake-up. (2) Markedly effective: sleep is clearly improved, sleep time increases by more than 3 h, and sleep depth increases. (3) Effective: the symptoms are alleviated, and the sleep time increases by <3 h compared with the previous period. (4) Invalid: no obvious improvement or aggravation after treatment. Total effective rate = [(number of clinically cured cases+number of markedly effective cases+number of effective cases)/total number of cases] × 100%. The acupuncturist completed the assessment at the end of treatment (week 2). We assessed the patient's emotional and psychological changes by the total score of SAS and SDS. If a total score of ≥50 indicates anxiety or depression, the higher the score, the more severe the symptoms (23). The acupuncturist completed the assessment before treatment, at the end of treatment (week 2) and during follow-up (weeks 6, 18, and 42).
The data collected from SSVEP were used to obtain the potential value through Fourier coefficients (24) (Figure 4). Equipment: HP Compaq Presario V3212 computer, UEA-16FZ EEG amplifier (Beijing Zhongke Xintuo Instrument Co., Ltd.), 16-channel Lycra electrode cap, EEG conductive paste (Jining High-tech Zone Jinnot Medical Gel Factory, batch number: 2013040), dedicated 5 ml conductive paste syringe, 3 M anti-noise earplugs. The steps followed by the acupuncturist for SSVEP data collection are as follows: (i) The acupuncturist asked the patient to sit down and let the patients wear earplugs. Measures were taken to avoid obvious yhead movement of the patients and inability to test questions. The door and windows were closed, and the lights were turned off. (ii) The acupuncturist disinfected the patients' skin of the head, and electrode pads were installed. (iii) Placement region for the brain on the patient's head were in accordance with international standards using electric collection point (2 reference electrodes, 16 recording electrodes). (iv) The acupuncturist injected the electrode paste and then started the scalp resistance test. (v) The acupuncturist put the flash stimulator ~30 cm in front of the patient's eyes and instructed the patient to look at the screen with both eyes. The acupuncturist then started to stimulate vision for 30 s with a frequency between 1 and 16 Hz. After a rest period of 2 s, the next frequency stimulation was started. The measurement was finished after 16 consecutive times. The low potential presents a blue image, which represents EEG inhibition; the high potential presents a red image, which represents EEG excitement. Potential difference = after treatment − before treatment. The acupuncturist completed the assessment before treatment and at the end of treatment (week 2).
2.8. Statistical analysis
The baseline characteristics and clinical results of this study were based on intention to treat (ITT) analysis. The included patients received at least 1 treatment and 1 primary outcome measurement. The measurement data was tested for normality first, the unpaired t-test or one-way ANOVA test was then used for normal distribution and homogeneity of variance, and the Wilcoxon Signed-Rank or Mann–Whitney U test was used for nonnormality testing. Enumeration data will be tested using χ2 analysis. Categorical variables are shown as numbers and percentages. Using the last observation carried forwards method, the missing data of participants who had dropped out were replaced. Using Statistical analysis SPSS® version 22.0, the difference was considered statistically significant at p < 0.05.
2.9. Quality control
This study was under the supervision of Chengdu University of Traditional Chinese Medicine. Our SSVEP data were analyzed and completed by experts from both the University of Electronic Science and Technology of the University of Life Science and Technology. In addition, a qualified expert in clinical trial research supervised this study.
3. Results
3.1. Baseline characteristics
A total of 162 patients were approached in this study, and 72 participants met the exclusion criteria. A total of 90 patients met the inclusion criteria (44 in the AA group and 46 in the SA group). We found that the average age of patients with insomnia was 38.77 years and that 64.4% of the subjects were women. The total PSQI scores of the AA group and the SA group in this study were 13.45 ± 1.76 and 13.17 ± 1.91, respectively. There were no significant differences in the SAS and SDS scores between the other two groups (p > 0.05) (Table 2).
3.2. Primary outcomes
After 2 weeks of intervention, the total PSQI score was 6.11 ± 2.33 in the AA group and 10.37 ± 4.73 in the SA group (t = −5.370, p < 0.05). During the whole follow-up period, although the total PSQI score of the AA group showed repeated increases to varying degrees, the long-term efficacy of the AA group was still better than that of the SA group (2 weeks: 6.27 ± 1.39 vs. 11.93 ± 3.07, t = –11.203, p < 0.05/18 weeks: 6.32 ± 2.84 vs. 11.78 ± 2.95, t = –8.940, p < 0.05/42 weeks: 8.05 ± 3.14 vs. 12.54 ± 2.81, t = –7.168, p < 0.05) (Table 3, Figure 5). We statistically analyzed 44 patients in the AA group according to the ages of 18–40, 41–55, and 56–65 years. It was found that the clinical effect of acupuncture was improved at any age (all p > 0.05) (Table 4).
3.3. Secondary outcomes
The SAS score in the AA group decreased to 39.59 ± 5.94 after 2 weeks of intervention, and it was 59.74 ± 6.15 in the SA group (t = –15.797, p < 0.05). The SDS scores of the two groups were 43.14 ± 10.79 and 61.20 ± 4.40, respectively (t = –10.480, p < 0.05). The SAS and SDS scores of the two groups were significantly different throughout the follow-up period (Table 5, Figure 6). After 10 treatments, the total effective rate of the AA group was 81.82%, while that of the SA group was 30.43% (χ2 = −5.454, p < 0.05). The most obvious difference was that the ratio of patients who were clinically cured or markedly improved in the AA group was significantly higher than that in the SA group (11:2; 19:3) (p < 0.05). The remaining results are shown in Table 5, Figure 7.
Table 5. Secondary outcomes (1).
After the treatment, the brain electrical potential changes in the frontal lobe, right temporal lobe, and occipital lobe in the patients from the AA group were significantly different (P < 0.05). Although there was a downwards trend in brain potentials in the SA group, there was no significant difference (P > 0.05). When the two groups were compared, there was no difference in the parietal lobe (F4), left temporal lobe (C3), or right temporal lobe (T8) between the AA group and the SA group (P > 0.05); however, there were statistically significant differences in brain electrical potential changes in other brain regions (P < 0.05). The difference in brain electrical potential changes in specific SSVEP is shown in Table 6, Figures 8, 9.
Table 6. Secondary outcomes (2).
In addition, our results also demonstrated a certain positive correlation between the total PSQI score, SAS score, efficacy level, and SSVEP value in the AA group. This positive correlation is reflected in the following results: C4 and the total score of PSQI (r = 0.595, P = 0.041), F3 and SAS score (r = 0.604, P = 0.037), FPz and the efficiency level of the frontal lobe (r = 0.581, P = 0.048), and O2 and efficiency level of the occipital lobe (r = 0.704, P = 0.011) (Figure 10).
Figure 10. The correlation between sleep improvement and the change in SSVEP values (active acupuncture group).
4. Discussion
In our study, we found that, compared with sham acupuncture, active acupuncture can significantly improve sleep quality and the clinical cure rate of insomnia. This effect can be maintained for a long time without being affected by age. At the same time, acupuncture has a significant downregulation effect on the SSVEP of abnormal brain excitement. This downregulation was positively correlated with clinical efficacy. Our study is one of the few that evaluated the observation of acupuncture for insomnia with mood disorders by clinical scales and SSVEP.
Acupuncture has long been used for the treatment of primary insomnia in China. Under current circumstances where oral medication is unfavorable, patients with insomnia often choose acupuncture as an alternative therapy. Compared with the use of drugs for the treatment of insomnia, acupuncture treatment can contribute to significant improvement in the symptoms of insomnia (25). Immediate and sustained effects are the two main manifestations of the curative effect of acupuncture. The onset of the effect of acupuncture on insomnia is a process of transitioning from “quantitative change” to “qualitative change”. The total treatment cycle and the time interval between acupuncture and the onset of symptoms are the two most significant factors influencing the sustained effect. According to the report, to maintain the continuity and stability of the acupuncture effect, it is necessary to compound the number of acupuncture treatments to achieve the best effect (26). Hachul and colleagues reported that there was a 3 point decline in the PSQI score after 10 sessions of acupuncture treatment (27). Fu et al. divided 10 acupuncture treatments into 2 weeks to improve the compliance of patients. After 10 treatments, the PSQI score of the acupuncture group decreased by 8.03 points from baseline, and the PSQI score of the sham acupuncture group decreased by 1.29 points from baseline (28). After 2 weeks of acupuncture treatment, the curative effect will reach a more obvious level and reach the extreme value at 4 weeks. Therefore, a total of 10 treatments were performed in 2 weeks in this study. The advantage is that such accumulation can not only result in therapeutic effects but also avoid the potential effects of excessive acupuncture and increase the body's tolerance.
Acupoints are not only a special place where Qi and blood are infused in the meridian but also the reaction points of the disease and the stimulation points of acupuncture. According to Chinese medicine theory, insomnia results from the vicious cycle of fatigue during the day or from a mental condition of extreme excitement at night. Therefore, this study selected Shenmen, Neiguan, Anmian, and other acupoints that are commonly used for treating insomnia (29). The Anmian is the traditional acupoint used to treat insomnia. Shenmen can calm the heart and spirit. Zusanli affects the spleen and regulates the stomach. Taichong regulates the liver and gallbladder. The Neiguan enlarges the chest and adjusts Qi (30). These acupoints can be used together to calm and soothe the mind and achieve hypnotic induction. The combination of Hegu and Taichong can regulate the liver and Qi. Zhaohai and Shenmai are special meridians and collaterals in the treatment of insomnia and have the advantage of regulating internal organs (31). In traditional Chinese medicine, “deqi” is believed to be the basis for effective results (32). Through acupuncture stimulation of certain acupoints that elicit “deqi” sensations, acupuncture can help restore the normal sleep-wake cycle by correcting the imbalance of Yin and Yang toward harmony.
Our study found that acupuncture treatment does not affect the natural sleep-wake cycle. After 10 acupuncture treatments, the patient's sleep quality and emotional state were significantly improved. In our study, the total PSQI score decreased from 13.45 ± 1.76 to 6.11 ± 2.33. This is still due to the real stimulation of the acupoints, so that the functions of the acupoints can be brought into play. Fu Cong et al. confirmed that the PSQI score decreased by 8.03 points after 10 acupuncture treatments (28). This is consistent with our research results. However, in the SA group, the blunt needle could not penetrate the skin, so the acupoints could not receive useful stimulation. Therefore, the sleep quality of the SA group was still poor. Other test results show that acupuncture can increase the content of serotonin and aminobutyric acid and reduce the level of glutamate (33). Therefore, acupuncture treatment can improve central inhibitory function and thus help people fall asleep (34). It has been reported that the correlation between insomnia and anxiety is 62.2%, and the correlation between insomnia and depression is 59.7%. This shows that insomnia and emotional disorders have a high degree of correlation (35). The frontal lobe is the thinking control center of the brain, which is closely related to the changes in cognitive functions of patients with depression, such as task execution, memory retrieval, information integration, and emotional regulation. Studies have shown that the frontal lobe, temporal lobe and the nerve circuits between them are significantly abnormal in patients with depression (36). It has been observed by resting-state functional magnetic resonance imaging (fMRI) that acupuncture at the Taichong point can inhibit the bilateral frontal lobe and most of the temporal lobe in patients with depression. The change in the frontal lobe may be one of the mechanisms of acupuncture treatment of depression (37). In our study, the SAS and SDS scores of the AA group decreased significantly. Regardless of treatment or follow-up, the improvement in emotional state in the AA group was better than that in the SA group. This situation, we believe, is inseparable from the relief of sleep disorders. Excitingly, the mood disturbances of insomnia patients improved synchronously and were consistent with the quality of sleep. This result has also been confirmed by animal experiments. Cheng Cisong et al. found that electroacupuncture at the Shenmen and Sanyinjiao points can inhibit the overexcitation of the sympathetic adrenal medullary system in rats with insomnia, thereby improving insomnia and alleviating anxiety and other emotional disorders (38). Previous studies have also confirmed that acupuncture can improve the sleep efficiency of patients with insomnia, extend their sleep, and improve insomnia severity (21).
Our results demonstrated that the AA group had better improvement in SSVEP brain potential than the SA group, especially in the frontal and occipital lobes. The frontal lobe is in front of the anterior central sulcus, which accounts for 40% of the cerebral cortex. It is the high-level executive center for brain activity where mental activity occurs. It is inseparably correlated with the symptoms of insomnia and anxiety. The occipital cortex is involved in visual processing. Studies have found that increased gray matter volumes in this cortex are associated with the levels of anxiety severity (39), which may be regulated through the frontoparietal connected networks (40). As the AA group effectively improved sleep quality, the abnormal excitation potential of the cerebral cortex was reduced; the response of the optic nerve in the occipital area was reduced when visual stimulation was received; and the abnormal brain potential of the frontal lobe was also downregulated. Interestingly, this study also found a certain positive correlation between the curative effect, SAS of the AA group and the SSVEP value. When the brain potentials of the frontal, parietal, and occipital lobes were downregulated, sleep quality and mood disorders were effectively adjusted. Using resting-state fMRI, studies have observed that acupuncture may improve sleep quality by regulating the local consistency of the prefrontal cortex and the parietal precuneus (41), which is consistent with our results. Other modern studies have also found that acupuncture can activate the thalamus, frontal lobe and other sleep central functions and can smooth emotions, relieve stress and improve sleep through different neural pathways (42, 43). Because the fibers from the thalamus project to the hypothalamus, the prefrontal lobe of the cerebral cortex, the orbital region or the posterior parietal lobe contact area, this also confirms that acupuncture can play a strong inhibitory role on the SSVEP potential values of the frontal lobe and the occipital lobe brain region, thus effectively improving insomnia and emotional disorders. Acupuncture treatment can not only effectively improve the quality of sleep and emotional state but also improve the quality of life for the subjects.
Visual evoked potentials are widely used in frontier fields such as brain-computer interfaces and are divided into instantaneous visual evoked potentials and steady-state visual evoked potentials. When vision is stimulated by an external stimulus at a constant frequency, the brain produces a response at the same frequency as the external stimulus frequency and its harmonics. The strength of this response can be represented by the voltage signal measured on the scalp, that is, SSVEP. Through cortical homeostasis probe morphology technology, studies have found that anxiety is related to the frontal, temporal, and occipital cortical areas (44). In addition, SSVEP are often used in research on depression, autism and migraine headaches (45, 46). Compared with polysomnography, SSVEP have a strong anti-interference ability and can monitor the dynamic changes in the cognitive process stimulated by external stimuli. Compared with fMRI, SSVEP do not have the problem of haemodynamic delay and are more economical, but they do not have the role of accurately positioning functional brain activation areas (47).
Using SSVEP, we made a new attempt to explore the effects of the brain electrical potential changes following acupuncture for the improvement of sleep quality. However, our study has some limitations, such as a small sample size and a lack of reference to polysomnography. Given the complexity of the disease and the diversification of research approaches, future research can explore the effective combination of SSVEP and fMRI technology to provide a more comprehensive approach to visual analysis of acupuncture treatment for insomnia (48).
In addition, there has been an increase in RCTs of acupuncture for the treatment of insomnia. However, due to variations in methodological quality, previous studies have yielded mixed results. Our study employed the PSD as the main research tool with real needles or blunt needles (49). During operations in which the blunt needle is used, the patient can see the doctor's acupuncture action but does not experience actual needle sensation (50). This is an effective single-blind control method (51, 52). In clinical research studies on acupuncture treatment in low back pain, temporomandibular arthritis, and other systemic diseases, their findings verified the reliability of the Park simulation needle (53, 54). Therefore, to improve the blinding effect, Park analog needles were used in our study in both the acupuncture group and the sham acupuncture group.
5. Conclusion
In summary, our research found that acupuncture has a good clinical effect on insomnia patients with emotional disorders and has a significant regulatory effect on abnormally excited brain potentials. Our results provide further evidence for the effectiveness and possible mechanism of acupuncture in treating sleep disorders.
Data availability statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Ethics statement
The studies involving human participants were reviewed and approved by the Sichuan Traditional Chinese Medicine (TCM) Regional Ethical Review Committee. The patients/participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.
Author contributions
Conceptualization: LZ and YD. Project administration: LZ, RH, and YT. Funding acquisition: YH and NL. Formal analysis: SY and YL. Writing—original draft: LZ. All authors contributed to the article and approved the submitted version.
Funding
The study was partly supported by the Science and Technology Bureau of Chengdu (Topological Characteristics of Steady-State Visual Evoked Potentials Acupuncture Improves Postinsomnia Emotional Disorder) [grant number 11DXYB146JH-027] and the Natural Science Foundation of Sichuan Province-Exploring the multidimensional regulatory mechanism of acupuncture on the default network of chronic spontaneous urticaria based on spatiotemporal analysis technology (No. 2022NSFSC1492).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. Edinger JD, Arnedt JT, Bertisch SM, Carney CE, Harrington JJ, Lichstein KL, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. (2021) 17:255–62. doi: 10.5664/jcsm.8986
2. Chung KF, Yeung WF, Yu YM, Ho YY. A population-based 2-year longitudinal study of insomnia disorder in a Chinese population in Hong Kong. Psychol Health Med. (2017) 23:1–6. doi: 10.1080/13548506.2017.1363397
3. Suh S, Cho N, Zhang J. Sex differences in insomnia: from epidemiology and etiology to intervention. Curr Psychiatry Rep. (2018) 20:69. doi: 10.1007/s11920-018-0940-9
4. Brouwer A, Raalte D, Rutters F, Elders P, Bremmer MA. Sleep and HbA 1c in patients with type 2 diabetes: which sleep characteristics matter most? Diabetes Care. (2019) 43:dc190550. doi: 10.2337/dc19-0550
5. Cai G-H, Theorell-Haglöw J, Janson C, Svartengren M, Elmståhl S, Lind L, et al. Insomnia symptoms and sleep duration and their combined effects in relation to associations with obesity and central obesity. Sleep Med. (2018) 2018:81. doi: 10.1016/j.sleep.2018.03.009
6. Taylor DJ, Mallory LJ, Lichstein KL, Durrence HH, Riedel BW, Bush AJ. Comorbidity of chronic insomnia with medical problems. Sleep. (2007) 30:213–8. doi: 10.1093/sleep/30.2.213
8. Riemann D, Krone L, Wulff K, Nissen C. Sleep, insomnia, and depression. Neuropsychopharmacology. (2020) 45:74–89. doi: 10.1038/s41386-019-0411-y
9. Gebara MA, Siripong N, DiNapoli EA, Maree RD, Germain A, Reynolds CF, et al. Effect of insomnia treatments on depression: A systematic review and meta-analysis. Depress Anxiety. (2018) 35:717–31. doi: 10.1002/da.22776
10. Wickwire E, Shaya F, Scharf S. Health economics of insomnia treatments: the return on investment for a good night's sleep. Sleep Med Rev. (2016) 30:72–82. doi: 10.1016/j.smrv.2015.11.004
11. Zhao F-Y, Fu Q-Q, Kennedy GA, Conduit R, Zhang W-J, Wu W-Z, et al. Can acupuncture improve objective sleep indices in patients with primary insomnia? A systematic review and meta-analysis. Sleep Med. (2021) 80:244–59. doi: 10.1016/j.sleep.2021.01.053
12. Zhang L, Tang Y, Hui R, Zheng H, Li Y. The effects of active acupuncture and placebo acupuncture on insomnia patients: a randomized controlled trial. Psychol Health Med. (2020) 25:1–15. doi: 10.1080/13548506.2020.1738015
13. Zhu F, Jiang L, Dong G, Gao X, Wang Y. An open dataset for wearable SSVEP-based brain-computer interfaces. Sensors (Basel, Switzerland). (2021) 21:1256. doi: 10.3390/s21041256
14. Park S, Kim D, Han C, Im C. Estimation of emotional arousal changes of a group of individuals during movie screening using steady-state visual-evoked potential. Front Neuroinform. (2021) 15:731236. doi: 10.3389/fninf.2021.731236
15. Wieser M, Miskovic V, Keil A. Steady-state visual evoked potentials as a research tool in social affective neuroscience. Psychophysiology. (2016) 53:1763–75. doi: 10.1111/psyp.12768
16. Schulz K, Altman D, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. (2010) 340:c332. doi: 10.1136/bmj.c332
17. MacPherson H, Altman DG, Hammerschlag R, Li Y, Wu T, White A, et al. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): Extending the CONSORT statement. PLoS Med. (2010) 7:35–46. doi: 10.1371/journal.pmed.1000261
18. Association. AP. Diagnostic and Statistical Manual of Mental Disorders, DSM-5. Washington, DC: American Psychiatric Publishing (2013).
19. Cheuk DK, Yeung WF, Chung KF, Wong V. Acupuncture for insomnia. Cochrane Database Syst Reviews. (2012) 9:CD005472. doi: 10.1002/14651858.CD005472.pub3
20. To M, Alexander C. The effects of Park sham needles: a pilot study. J Integr Med. (2015) 13:20–4. doi: 10.1016/S2095-4964(15)60153-4
21. Yin X, Gou M, Xu J, Dong B, Yin P, Masquelin F, et al. Efficacy and safety of acupuncture treatment on primary insomnia: a randomized controlled trial. Sleep Med. (2017) 37:193–200. doi: 10.1016/j.sleep.2017.02.012
22. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. (1989) 28:193–213. doi: 10.1016/0165-1781(89)90047-4
23. Wu X-K, Stener-Victorin E, Kuang H-Y, Ma H-L, Gao J-S, Xie L-Z, et al. Effect of acupuncture and clomiphene in chinese women with polycystic ovary syndrome: a randomized clinical trial. JAMA. (2017) 317:2502–14. doi: 10.1001/jama.2017.7217
24. Zhong J, Shuren Q. Principle and Implementation of Weak Biomedical Signal Feature Extraction. Beijing, China: Science Press (2007).
25. Kim S-A, Lee S-H, Kim J-H, van den Noort M, Bosch P, Won T, et al. Efficacy of Acupuncture for Insomnia: A Systematic Review and Meta-Analysis. Am J China Med. (2021) 49:1135–50. doi: 10.1142/S0192415X21500543
26. Lin LL, Wang LQ, Yang JW, Tu JF, Wang TQ, Zou X, et al. Researches status on time-effect of acupuncture. Zhongguo Zhen Jiu. (2019) 39:565–70. doi: 10.13703/j.0255-2930.2019.05.029
27. Hachul H, Garcia TK, Maciel AL, Yagihara F, Tufik S, Bittencourt L. Acupuncture improves sleep in postmenopause in a randomized, double-blind, placebo-controlled study. Climacteric. (2013) 16:36–40. doi: 10.3109/13697137.2012.698432
28. Fu C, Zhao N, Liu Z, Yuan L-H, Xie C, Yang W-J, et al. Acupuncture improves peri-menopausal insomnia: a randomized controlled trial. Sleep. (2017) 40:zsx153. doi: 10.1093/sleep/zsx153
29. Qiongqiong Z, Ping L, Jinlei Z, Yuanxiang L. Research on clinical acupoint selection rules of acupuncture and moxibustion in the treatment of insomnia based on data mining in the past 30 years. World Sci Technol Modern Trad Chin Med. (2018) 20:1596–602. doi: 10.11842/wst.2018.09.016
30. Huo Z, Guo J, Li D. Effects of acupuncture with meridian acupoints and three Anmian acupoints on insomnia and related depression and anxiety state. Chin J Integr Med. (2013) 19:187–91. doi: 10.1007/s11655-012-1240-6
31. Wang C, Xu W-L, Li G-W, Fu C, Li J-J, Wang J, et al. Impact of acupuncture on sleep and comorbid symptoms for chronic insomnia: a randomized clinical trial. Nat Sci Sleep. (2021) 13:1807–22. doi: 10.2147/NSS.S326762
32. Sun R, He Z, Ma P, Yin S, Yin T, Liu X, et al. The participation of basolateral amygdala in the efficacy of acupuncture with deqi treating for functional dyspepsia. Brain Imaging Behav. (2021) 15:216–30. doi: 10.1007/s11682-019-00249-7
33. Liu Z, Chen X, Gao Y, Sun S, Yang L, Yang Q, et al. Involvement of GluR2 up-regulation in neuroprotection by electroacupuncture pretreatment via cannabinoid CB1 receptor in mice. Sci Rep. (2015) 5:9490. doi: 10.1038/srep09490
34. Zhao K. Acupuncture for the treatment of insomnia. Int Rev Neurobiol. (2013) 111:217–34. doi: 10.1016/B978-0-12-411545-3.00011-0
35. Xiaojun W, Hong Y, Jun L. A clinical study on the correlation between insomnia and anxiety and depression. Chin J Misdiag. (2009) 9:5325–6.
36. Abe N, Suzuki M, Mori E, Itoh M, Fujii T. Deceiving others: distinct neural responses of the prefrontal cortex and amygdala in simple fabrication and deception with social interactions. Cogn Neurosci J. (2007) 19:287–95. doi: 10.1162/jocn.2007.19.2.287
37. Yang Y, Fangming X, Hongwu X, Yune S, Fajin L, Peng X, et al. A resting-state functional magnetic resonance study on the relationship between liver meridian and frontal lobe in the treatment of depression with Taichong Acupuncture. Chin J Integr Trad Chin West Med. (2011) 31:1044–50.
38. Cicong C, Ping L, Qiwen W, Zhendong Z, Jun K, Peipei W, et al. Effect of electroacupuncture on anxiety state and sympathoadrenal medulla system in insomnia model rats. Chin Acupunct Moxibust. (2015) 35:923–6. doi: 10.13703/j.0255-2930.2015.09.020
39. Frick A, Engman J, Alaie I, Björkstrand J, Faria V, Gingnell M, et al. Enlargement of visual processing regions in social anxiety disorder is related to symptom severity. Neurosci Lett. (2014) 583:114–9. doi: 10.1016/j.neulet.2014.09.033
40. Li K, Zhang M, Zhang H, Li X, Zou F, Wang Y, et al. The spontaneous activity and functional network of the occipital cortex is correlated with state anxiety in healthy adults. Neurosci Lett. (2020) 715:134596. doi: 10.1016/j.neulet.2019.134596
41. Fan Z. Acupuncture regulating excessive arousal of chronic insomnia with deficiency of heart and spleen (Doctoral dissertation). Beijing University of Traditional Chinese Medicine, Beijing, China (2019).
42. Lu J, Greco MA, Shiromani P, Saper CB. Effect of lesions of the ventrolateral preoptic nucleus on NREM and REM sleep. J Neurosci. (2000) 20:3830. doi: 10.1523/JNEUROSCI.20-10-03830.2000
43. Quan Z, Dayan Y, Xiao C, Kanrong Y, Jie L, Canghuan Z. Effect of electroacupuncture at Shenmen and Sanyinjiao on insomnia: an fMRI study. Chin J Interven Radiol. (2011) 8:204–7. doi: 10.1007/s10570-010-9464-0
44. Gray M, Kemp AH, Silberstein RB, Nathan PJ. Cortical neurophysiology of anticipatory anxiety: an investigation utilizing steady state probe topography (SSPT). Neuroimage. (2003) 20:975–86. doi: 10.1016/S1053-8119(03)00401-4
45. Moratti S, Rubio G, Campo P, Keil A, Ortiz T. Hypofunction of right temporoparietal cortex during emotional arousal in depression. Arch Gen Psychiatry. (2008) 65:532–41. doi: 10.1001/archpsyc.65.5.532
46. Shibata K, Yamane K, Otuka K, Iwata M. Abnormal visual processing in migraine with aura: a study of steady-state visual evoked potentials. J Neurol Sci. (2008) 271:119–26. doi: 10.1016/j.jns.2008.04.004
47. Yu S, Shen Z, Lai R, Feng F, Guo B, Wang Z, et al. The orbitofrontal cortex gray matter is associated with the interaction between insomnia and depression. Front Psychiatry. (2018) 4:651. doi: 10.3389/fpsyt.2018.00651
48. Ji H, Chen B, Petro N, Yuan Z, Zheng N, Keil A. Functional source separation for EEG-fMRI fusion: application to steady-state visual evoked potentials. Front Neurorobot. (2019) 13:24. doi: 10.3389/fnbot.2019.00024
49. Park J, White A, Lee H, Ernst E. Development of a new sham needle. Acupunct Med. (1999) 8:110–2. doi: 10.1136/aim.17.2.110
50. Park JJ. Developing and validating a sham acupuncture needle. Acupunct Med. (2009) 27:93. doi: 10.1136/aim.2009.001495
51. Streitberger K, Kleinhenz J. Introducing a placebo needle into acupuncture research. Lancet. (1998) 352:364–5. doi: 10.1016/S0140-6736(97)10471-8
52. Maciel LYDS. Comparison of the placebo effect between different non-penetrating acupuncture devices and real acupuncture in healthy subjects: a randomized clinical trial. BMC Complement Altern Med. (2016) 16:518. doi: 10.1186/s12906-016-1477-2
53. Smith P, Mosscrop D, Davies S, Sloan P, Al-Ani Z. The efficacy of acupuncture in the treatment of temporomandibular joint myofascial pain: A randomised controlled trial. J Dent. (2007) 35:259–67. doi: 10.1016/j.jdent.2006.09.004
Keywords: acupuncture, sham acupuncture, insomnia, anxiety, depression, SSVEP, electroencephalogram
Citation: Zhang L, Deng Y, Hui R, Tang Y, Yu S, Li Y, Hu Y and Li N (2023) The effects of acupuncture on clinical efficacy and steady-state visual evoked potentials in insomnia patients with emotional disorders: A randomized single-blind sham-controlled trial. Front. Neurol. 13:1053642. doi: 10.3389/fneur.2022.1053642
Received: 26 September 2022; Accepted: 13 December 2022;
Published: 18 January 2023.
Edited by:
Xi-jian Dai, Second Affiliated Hospital of Nanchang University, ChinaReviewed by:
Chuanhai Cao, University of South Florida, United StatesMailan Liu, Hunan University of Chinese Medicine, China
Copyright © 2023 Zhang, Deng, Hui, Tang, Yu, Li, Hu and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Youping Hu, hypcdutcm@yeah.net; Ning Li, zhenjiuhuaxi@163.com